Jefferson , T. ; Del Mar , C. ; Dooley , L. ; Ferroni , E. ; Al-Ansary , L. A ; Bawazeer , G. A ; van Driel , M. L ; Foxlee , R. ; Rivetti , A. ( 22 September 2009 ) .
1,2 person
1,2 person|5,7 person|5,9 person|5,13 person|5,22 person|5,33 person|10,11 person|14,15 person|18,19 person|18,22 person|20,22 person|23,24 person|23,33 person|25,27 person|25,33 person|28,33 person|31,33 person|34,35 person|36,37 person|38,39 person|40,41 person|43,44 time|43,45 time|44,45 time

Chan , An-Wen ; Song , Fujian ; Vickers , Andrew ; Jefferson , Tom ; Dickersin , Kay ; Gøtzsche , Peter C ; Krumholz , Harlan M ; Ghersi , Davina ; van der Worp , H Bart ( January 2014 ) .
1,2 person
1,8 person|1,12 person|1,16 person|9,12 person|13,16 person|17,18 person|21,22 person|26,27 person|28,30 person|31,32 person|33,34 person|35,38 person|39,41 person|42,44 time

He has said that the studies claiming large reductions in mortality rates as a result of the influenza vaccine are " rubbish " , [ 1 ] and that " influenza vaccines are about marketing and not science " . [ 7 ]
1,2 person
1,2 person|8,13 abstract|11,13 abstract|11,13 quantity|17,20 abstract|17,20 substance|18,20 substance|31,33 abstract|31,33 substance|35,36 abstract|38,39 abstract|42,43 abstract

His views about the effectiveness of influenza vaccines and his outspokenness about them are also controversial ; at a 2007 meeting on pandemic preparedness he was shunned by other vaccine researchers and ate alone . [ 1 ]
1,2 person
1,2 person|1,9 abstract|1,14 abstract|4,9 abstract|7,9 substance|10,11 person|13,14 abstract|20,21 time|23,25 abstract|25,26 person|29,32 person|37,38 abstract

As the company , Roche , that did the trials refused to provide data for independent analysis , their conclusions in 2009 were that benefits could not be shown . [ 4 ]
1,2 person
2,4 organization|5,6 organization|9,11 event|16,18 abstract|19,20 person|19,21 abstract|22,23 time|25,26 abstract|32,33 abstract

He has called repeatedly for placebo-controlled randomized clinical trials to prove the efficacy of flu vaccines , a position that most in the field hold as unethical . [ 1 ]
1,2 person
1,2 person|6,10 event|12,17 abstract|15,16 animal|15,17 object|18,20 abstract|21,25 person|23,25 abstract|30,31 abstract

" Effects of editorial peer review : a systematic review " . JAMA . 287 ( 21 ) : 2784 – 6 . doi : 10.1001/jama.287.21.2784 . PMID 12038911 .
1,2 person
2,7 abstract|4,7 abstract|8,11 abstract

In 2012 , Jefferson was the lead author of another Cochrane review of this data which concluded that oseltamivir did not reduce the number of hospitalizations caused by influenza .
1,2 person
2,3 time|4,5 person|6,12 person|10,16 abstract|14,16 abstract|19,20 substance|23,27 quantity

Jefferson is an author and editor of the Cochrane Collaboration 's acute respiratory infections group , as well as part of four other Cochrane groups . [ 2 ]
1,2 person
1,2 person|3,11 person|3,12 person|3,16 person|8,12 organization|9,12 organization|12,16 abstract|22,26 person|28,29 abstract

In 2011 Jefferson 's team was provided 22,000 pages of data from the European Medicines Agency and Roche eventually provided 3,000 pages of data . [ 4 ]
1,2 person
2,3 time|3,5 person|8,12 quantity|13,17 organization|18,19 organization|21,25 quantity|27,28 abstract

Measuring the quality of editorial peer review " . JAMA . 287 ( 21 ) : 2786 – 90 . doi : 10.1001/jama.287.21.2786 . PMID 12038912 .
1,2 person
2,8 abstract|5,8 abstract

" The evidence base for new drugs " . BMJ . 350 ( mar02 6 ) : h952 – h952 . doi : 10.1136/bmj . h952 .
1,2 person
2,8 abstract|6,8 substance|10,11 organization|14,16 time|18,19 abstract|20,21 abstract

Jefferson was one of the founding members of the Brighton Collaboration along with Harald Heijbel , Ulrich Heininger , and Elisabeth Loupi . [ 3 ]
1,2 person
1,2 person|3,12 person|14,16 person|17,19 person|21,23 person|25,26 abstract

Previous researchers had published trials without seeing the underlying data and it appeared that some of the published papers used ghost writers . [ 4 ]
1,2 person
1,3 person|8,11 abstract|15,20 abstract|15,20 object|21,23 person|25,26 abstract

Jefferson , T ; Di Pietrantonj , C ; Debalini , MG ; Rivetti , A ; Demicheli , V ( July 2009 ) .
1,2 person
1,2 person|5,7 person|10,11 person|14,15 person|16,17 person|18,19 person|20,21 person|22,23 time|22,24 time|23,24 time

Reviews led by Jefferson have concluded that there is insufficient evidence to show that influenza vaccines reduce mortality or infection rates . [ 6 ]
1,2 person
1,2 abstract|4,5 person|11,12 abstract|15,17 substance|18,19 quantity|20,22 abstract|24,25 abstract

is a British epidemiologist , based in Rome , Italy , [ 1 ] who works for the Cochrane Collaboration .
1,2 person
8,11 place|10,11 place|18,21 organization|19,21 organization

He has worked on Cochrane reviews examining the effectiveness of the anti-viral oseltamivir and the influenza vaccine . [ 4 ]
1,2 person
1,2 person|5,7 abstract|8,18 abstract|20,21 abstract

Jefferson was hired by the governments of Britain and Australia to update a systematic review of oseltamivir . [ 4 ]
1,2 person
1,2 person|5,9 organization|5,11 organization|8,9 place|10,11 place|17,18 substance|20,21 abstract

Jefferson , T ; Alderson , P ; Wager , E ; Davidoff , F ( 5 June 2002 ) .
1,2 person
1,2 person|5,6 person|9,10 person|11,12 person|13,14 person|15,16 person|17,20 time|18,20 time

. 339 ( sep21 1 ) : b3675 – b3675 . doi : 10.1136/bmj . b3675 . PMC 2190272 .
1,2 person
10,11 abstract

Jefferson said that this review also found no evidence that oseltamivir stopped complications from the disease . [ 5 ]
1,2 person
1,2 person|4,6 abstract|4,6 event|11,12 substance|15,17 abstract|19,20 abstract

. 62 ( 7 ) : 677 – 86 . doi : 10.1016/j . jclinepi.2008.07.001 . PMID 19124222 .
1,2 person


( 9913 ) : 257 – 266 . doi : 10.1016/S0140-6736(13)62296-5 . PMC 4533904 . PMID 24411650 .
1,2 person
1,3 time|17,18 quantity

He is also an advisor to the Italian National Agency for Regional Health Services . [ 2 ]
1,2 person
1,2 person|4,15 person|7,15 organization|12,15 abstract|17,18 abstract

Initially he had a great deal of trouble getting results of the original trials . [ 4 ]
1,2 person
2,3 person|4,9 abstract|12,15 event|17,18 abstract

Jefferson , T ; Wager , E ; Davidoff , F ( 5 June 2002 ) .
1,2 person
1,2 person|5,6 person|7,8 person|9,10 person|11,12 person|13,16 time|14,16 time

" Physical interventions to interrupt or reduce the spread of respiratory viruses : systematic review "
1,2 person
8,13 abstract|8,16 abstract|14,16 abstract

His views on flu vaccines are opposed by the medical establishment . [ 1 ]
1,2 person
1,2 person|1,6 abstract|4,6 substance|9,12 organization|14,15 abstract

Doshi , P. ; Jefferson , T. ( 2 March 2015 ) .
1,2 person
1,2 person|1,8 person|3,4 person|5,6 person|5,8 person|7,8 person|9,12 time|10,12 time|11,12 time

Inactivated influenza vaccines : methods , policies , and politics " .
1,2 person
7,8 abstract|10,11 abstract

" Increasing value and reducing waste : addressing inaccessible research "
1,2 person
2,4 abstract|6,7 abstract|9,11 abstract

Jefferson ( epidemiologist )
1,2 person
1,2 person|3,4 abstract

Journal of Clinical Epidemiology
1,2 person
1,5 abstract

The Lancet
1,2 person
1,3 abstract

Tom Jefferson
1,2 person
1,3 person

In 1999
1,2 person
2,3 time

Notable work
1,2 person
1,3 abstract

In 2009
1,2 person
2,3 time

BMJ
1,2 person
1,2 organization

383
1,2 person


Tom
1,2 person


Publications
1,2 person
1,2 abstract

"
1,2 person


"
1,2 person


.
1,2 person


.
1,2 person

